Type II Diabetes Study

ONGOING STUDY!

We are investigating the potential effects of consuming a probiotic on haemoglobin A1c levels (your long-term indicator of glucose control) in people diagnosed with Type II Diabetes.

Eligibility criteria:

  • Be aged 18-75
  • Have a BMI between 18.5-45.0
  • Have Type II Diabetes treated with:
  • - Exercise + Diet OR
  • - Exercise + Diet + Metformin

WHAT IS INVOLVED:

  • Consuming the probiotics, twice daily, for 12 weeks
  • Attend our clinic 7 times
  • Wear a Continuous Glucose Monitor (CGM) for 12 weeks
  • Perform a Standardised Tolerance Test (STT)

Continuous Glucose Monitoring (CGM) is a method to track glucose levels throughout the day and night. The CGM contains a small sensor wire that is places just under the skin to measure your glucose. It stores these readings, which can then be transferred wirelessly to a remote device.

The test involves inserting a cannula, which is a a thin tube that allows for a number of blood draws without the need to insert additional needles each time. 
There will be 3 blood draws over the course of 2 hours for the test, taking a total of 25.5mLs of blood. One blood draw before you consume the probiotic, with other draws taken at 60 and 120 minutes after consumption
You will be cannulated on Visits 2-6

If you are unsure of your BMI, please check it using the below link. It must be between 18.5-45.0 for you to be eligible for this study

Please click the button below to complete the Pre-Screening Questionnaire to help us determine your eligibility for the trial


Study visits take place in Atlantia Food Trials HQ in Heron House Offices, 1st Floor, Blackpool Retail Park, Cork.
All participants will receive reimbursement of €575 upon completion of the study.
Refer a friend and receive €50 if they participate.

For further information:
+353 (0)21 430 7442
studies@atlantiafoodtrials.com